Relationship of Comorbidity and Age to the Severity of Clinical Symptoms of COVID-19 at Mataram University Hospital
Authors
I Made Arya Yogiswara Mahayasa , Moulid Hidayat , Prima Belia Fathana , Indana Eva AjmalaDOI:
10.29303/jbt.v23i1.4581Published:
2023-01-12Issue:
Vol. 23 No. 1 (2023): January - MarchKeywords:
age, comorbidities, COVID-19, symptom severityArticles
Downloads
How to Cite
Downloads
Metrics
Abstract
COVID-19 disease is a disease that arises due to infection with the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The purpose of this study was to determine differences in clinical symptoms in elderly and non-elderly patients, as well as patients who had comorbidities and did not have comorbidities. This research is a type of cross-sectional study that was conducted by reviewing the medical records of COVID-19 patients undergoing treatment at Mataram University Hospital in 2021. Data was collected using a consecutive sampling technique. The statistical test used is the Chi-square comparative test. To assess the relationship of age and comorbidities to the severity of symptoms in COVID-19 patients. In this study, 86 subjects were selected based on the inclusion and exclusion criteria applied. The majority of subjects were in the 15-59 year age group, namely 66 (23.3%). With male sex 51 (60.5%) people. The majority of patients with comorbidities experienced severe/critical symptoms 16 (44.4%) and patients without comorbids experienced no symptoms or experienced mild symptoms 35 (35%). The majority of elderly patients experienced severe-critical symptoms 9 (45%) and the majority of non-elderly patients experienced no symptoms or experienced mild symptoms 42 (63.6%). The results of the bivariate analysis test showed a p-value = 0.001 for comorbids with severe symptoms, and a p-value = 0.003 for age with severe symptoms. There is a significant relationship between comorbidities and age on the severity of symptoms in COVID-19 patients.
References
Atmaja, K.S., Wicaksana, A.A.G.O.S., Putra, I.W.A.S. and Putra, W.W.S. (2021) ‘Hubungan konsentrasi serum C-Reactive Protein dan D-dimer dengan derajat keparahan dan mortalitas pasien COVID-19’, Intisari Sains Medis, 12(2), p. 680. Available at: https://doi.org/10.15562/ism.v12i2.971.
Daud, M.L., Nelwan, J.E. and Ratag, B.T. (2022) ‘Hubungan Antara Umur Dan Jenis Kelamin Dengan Kejadian Coronavirus Disease-19 Di Kota Bitung Tahun 2020’, Jurnal KESMAS, 11(1), pp. 190–195.
Diskominfotik NTB (2022) COVID-19 NTB. Available at: https://corona.ntbprov.go.id/ (Accessed: 20 October 2022).
Djaharuddin, I., Munawwarah, S., Nurulita, A., Ilyas, M., Tabri, N.A. and Lihawa, N. (2021) ‘Comorbidities and mortality in COVID-19 patients’, Gaceta Sanitaria, 35(January), pp. S530–S532. Available at: https://doi.org/10.1016/j.gaceta.2021.10.085.
Drew, C. and Adisasmita, A.C. (2021) ‘Gejala dan komorbid yang memengaruhi mortalitas pasien positif COVID-19 di Jakarta Timur, Maret-September 2020’, Tarumanagara Medical Journal, 3(2), pp. 274–283. Available at: https://journal.untar.ac.id/index.php/tmj/article/view/11742.
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX. (2020) ‘Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis’, European Respiratory Journal, 55(5), p. 2000547. Available at: https://doi.org/10.1183/13993003.00547-2020.
Ichsan, M.N., Kusadhiani, I. and Latuconsina, V.Z. (2022) ‘Hubungan Komorbid Dengan Durasi Perawatan Pasien Covid-19 Pada Rs Bayangkara Dan Rs Tk. Ii Prof. Dr. Ja. Latumeten Di Kota Ambon Tahun 2020’, Molucca Medica, 15(1), pp. 29–40. Available at: https://doi.org/10.30598/molmed.2022.v15.i1.29.
Khaerunnisa, R., Aula Rumana, N., Yulia, N. and Fannya, P. (2022) ‘Gambaran Karakteristik Pasien Covid-19 di Rumah Sakit Mekar Sari Bekasi Tahun 2020-2021’, Jurnal Manajemen Informasi Kesehatan Indonesia, 10(1), pp. 64–72.
Klhůfek, J. (2022) ‘The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero?’, Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine, 77(1), pp. 211–218. Available at: https://doi.org/10.1080/17843286.2020.1786324.
Kordzadeh-Kermani, E., Khalili, H. and Karimzadeh, I. (2020) ‘Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)’, Future Microbiology, 15(13), pp. 1287–1305. Available at: https://doi.org/10.2217/FMB-2020-0110.
Li, X., Li, T. and Wang, H. (2020) ‘Treatment and prognosis of COVID‑19: Current scenario and prospects (Review)’. Available at: https://doi.org/10.3892/etm.2020.9435.
Merga, B.T., Ayana, G.M., Raru, T.B., Alemu, A., Negash, B., Bekana, M., Birhanu, A. and Dessie, Y. (2022) ‘Association of Pre-Existing Comorbidities with Disease Severity Among COVID-19 Patients in Eastern Ethiopia’, Infection and Drug Resistance, 15(May), pp. 2825–2834. Available at: https://doi.org/10.2147/IDR.S362140.
Monod M, Blenkinsop A, Xi X, Hebert D, Bershan S, Tietze S, Baguelin M, Bradley VC, Chen Y, Coupland H, Filippi S, Ish-Horowicz J, McManus M, Mellan T, Gandy A, Hutchinson M, Unwin HJT, van Elsland SL, Vollmer MAC, Weber S, Zhu H, Bezancon A, Ferguson NM, Mishra S, Flaxman S, Bhatt S, Ratmann O. (2021) ‘Age groups that sustain resurging COVID-19 epidemics in the United States’, Science, 371(6536). Available at: https://doi.org/10.1126/science.abe8372.
Osibogun A, Balogun M, Abayomi A, Idris J, Kuyinu Y, Odukoya O, Wright O, Adeseun R, Mutiu B, Saka B, Osa N, Lajide D, Abdus-Salam I, Osikomaiya B, Onasanya O, Adebayo B, Oshodi Y, Adesola S, Adejumo O, Erinoso O, Abdur-Razzaq H, Bowale A, Akinroye K. (2021) ‘Outcomes of COVID-19 patients with comorbidities in southwest Nigeria’, PLoS ONE, 16(3 March), pp. 1–12. Available at: https://doi.org/10.1371/journal.pone.0248281.
Putra, I.M.A.A. and Fenty (2022) ‘Hubungan Komorbiditas Terhadap Derajat Keparahan Aadmisi dan Ooutcome Pasien COVID-19’, 1(1), pp. 11–18.
Ratshikhopha, E., Muvhali, M., Naicker, N., Tlotleng, N., Jassat, W. and Singh, T. (2022) ‘Disease Severity and Comorbidities among Healthcare Worker COVID-19 Admissions in South Africa: A Retrospective Analysis’, International Journal of Environmental Research and Public Health, 19(9). Available at: https://doi.org/10.3390/ijerph19095519.
Santika, I.G.P.N.A. (2015) ‘Hubungan Indeks Massa Tubuh (IMT) dan Umur Terhadap Daya Tahan Umum (Kardiovaskuler) Mahasiswa Putra Semester II Kelas A Fakultas Pendidikan Olahraga dan Kesehatan IKIP PGRI Bali Tahun 2014’, 1, p. 32.
Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., Hosein, Z., Padda, I., Mangat, J. and Altaf, M. (2020) ‘Comorbidity and its Impact on Patients with COVID-19’, SN Comprehensive Clinical Medicine, 2(8), pp. 1069–1076. Available at: https://doi.org/10.1007/s42399-020-00363-4.
Satuan Tugas Penanganan COVID-19 (2022) Peta Sebaran | Covid19.go.id. Available at: https://covid19.go.id/peta-sebaran (Accessed: 19 September 2022).
Susilo, A., Rumende, C.M., Pitoyo, C.W., Santoso, W.D., Yulianti, M., Herikurniawan, H., Sinto, R., Singh, G., Nainggolan, L., Nelwan, E.J., Chen, L.K., Widhani, A., Wijaya, E., Wicaksana, B., Maksum, M., Annisa, F., Jasirwan, C.O.M. and Yunihastuti, E. (2020) ‘Coronavirus Disease 2019: Tinjauan Literatur Terkini’, Jurnal Penyakit Dalam Indonesia, 7(1), p. 45. Available at: https://doi.org/10.7454/jpdi.v7i1.415.
Tuty Kuswardhani, R.A., Henrina, J., Pranata, R., Anthonius Lim, M., Lawrensia, S. and Suastika, K. (2020) ‘Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis’, Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(6), pp. 2103–2109. Available at: https://doi.org/10.1016/j.dsx.2020.10.022.
Wishnuwardhana, M., Nindya, M., Fernandez, G. and Jovito, A. (2022) ‘Comorbidities and COVID-19 severity in pediatric patients: systematic review and meta-analysis’, Paediatrica Indonesiana(Paediatrica Indonesiana), 62(1), pp. 51–60. Available at: https://doi.org/10.14238/pi62.1.2022.51-60.
Yuki, K., Fujiogi, M. and Koutsogiannaki, S. (2020) ‘COVID-19 pathophysiology: A review’, Clinical Immunology, 215(April). Available at: https://doi.org/10.1016/j.clim.2020.108427.
Yuliana, Y. (2020) ‘Corona virus diseases (Covid-19): Sebuah tinjauan literatur’, Wellness And Healthy Magazine, 2(1), pp. 187–192. Available at: https://doi.org/10.30604/well.95212020.
License
Copyright (c) 2023 I Made Arya Yogiswara Mahayasa, Moulid Hidayat, Prima Belia Fathana, Indana Eva Ajmala
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.